Lupin Limited, through its wholly owned subsidiary VISUfarma B.V., has entered into an exclusive licensing agreement with Visus Therapeutics, Inc. (a subsidiary of Tenpoint Therapeutics) to commercialize YUVEZZI™, a once-daily dual-agent eye drop for...
🧵 continued ↓
Lupin Limited, through its wholly owned subsidiary VISUfarma B.V., has entered into an exclusive licensing agreement with Visus Therapeutics, Inc. (a subsidiary of Tenpoint Therapeutics) to commercialize YUVEZZI™, a once-daily dual-agent eye drop for...
🧵 continued ↓
By: Scott Einsmann on Wednesday, July 15, 2026
By: Scott Einsmann on Wednesday, July 15, 2026
https://www.byteseu.com/2193845/
LONDON and WARREN, N.J.,—Tenpoint Therapeutics, Ltd., a global commercial-stage ophthalmic pharmaceutical company focused on developing treatments to improve vision in the …
https://www.byteseu.com/2193845/
LONDON and WARREN, N.J.,—Tenpoint Therapeutics, Ltd., a global commercial-stage ophthalmic pharmaceutical company focused on developing treatments to improve vision in the …
https://www.byteseu.com/2192246/
YUVEZZI received …
https://www.byteseu.com/2192246/
YUVEZZI received …
By: Jonathon Klein on Thursday, April 16, 2026
By: Jonathon Klein on Thursday, April 16, 2026
https://blackwirein.tel/article/beijing-unveils-tenpoint-economic-incentive-package-for-taiwan-amid-heightened-crossstrait-tensions
#China #War
https://blackwirein.tel/article/beijing-unveils-tenpoint-economic-incentive-package-for-taiwan-amid-heightened-crossstrait-tensions
#China #War
Yuvezzi, an eye drop for the treatment of presbyopia, is now available in the U.S.
According to a press release from Tenpoint Therapeutics, patients can…
Yuvezzi, an eye drop for the treatment of presbyopia, is now available in the U.S.
According to a press release from Tenpoint Therapeutics, patients can…
Yuvezzi, an eye drop for the treatment of presbyopia, is now available in the U.S.
According to a press release from Tenpoint… #ophthalmology #eye #eyenews
Yuvezzi, an eye drop for the treatment of presbyopia, is now available in the U.S.
According to a press release from Tenpoint… #ophthalmology #eye #eyenews